Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Laudani

Showing results (61-70 of 71) with videos related to

Pageof 8
Sort By:
JACC. Cardiovascular Interventions|May 26, 2026
Oral Anticoagulation With or Without Antiplatelet Therapy in Chronic Coronary Syndrome: A Meta-Analysis of Randomized TrialsMattia Galli, Mattia Vinciguerra, Claudio Laudani, et al.
Journal of the American College of Cardiology|September 2, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patientsMattia Galli, Stefano Benenati, Claudio Laudani, et al.
European Heart Journal Open|December 19, 2024
Older women with non-ST-elevation acute coronary syndrome undergoing invasive or conservative management: an individual patient data meta-analysisFrancesca Rubino, Graziella Pompei, Gregory B Mills, et al.
European Heart Journal|May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differencesClaudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
Journal of Cardiovascular Development and Disease|June 25, 2025
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction-DAPA-STEMI TrialLuis Ortega-Paz, Claudio Laudani, Alessandro Sionis, et al.
Journal of Clinical Medicine|June 12, 2026
Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized TrialLuis Ortega-Paz, Claudio Laudani, Carlos Igor Morr, et al.
Journal of the American Heart Association|February 25, 2025
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation TestingRiccardo Rinaldi, Michele Russo, Giovanni Occhipinti, et al.
Clinical Pharmacology and Therapeutics|August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated ParticipantsLuis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
International Journal of Cardiology|February 16, 2024
Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric studyFrancesco Bruno, Ovidio de Filippo, Andrea Sardone, et al.
Heart (British Cardiac Society)|April 29, 2026
Derivation and validation of a prediction model for long-term mortality in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the PREDICT-ST-Elevation Myocardial Infarction scoreLuis Ortega-Paz, Claudio Laudani, Salvatore Brugaletta, et al.
Pageof 8

Showing results (61-70 of 71) with videos related to

Sort By:
Pageof 8
JACC. Cardiovascular Interventions|May 26, 2026
Oral Anticoagulation With or Without Antiplatelet Therapy in Chronic Coronary Syndrome: A Meta-Analysis of Randomized TrialsMattia Galli, Mattia Vinciguerra, Claudio Laudani, et al.
Journal of the American College of Cardiology|September 2, 2025
Cardiovascular Effects and Tolerability of GLP-1 Receptor Agonists: A Systematic Review and Meta-Analysis of 99,592 patientsMattia Galli, Stefano Benenati, Claudio Laudani, et al.
European Heart Journal Open|December 19, 2024
Older women with non-ST-elevation acute coronary syndrome undergoing invasive or conservative management: an individual patient data meta-analysisFrancesca Rubino, Graziella Pompei, Gregory B Mills, et al.
European Heart Journal|May 19, 2026
Aspirin vs clopidogrel in chronic coronary syndromes: a meta-analysis of ethnic differencesClaudio Laudani, Giovanni Occhipinti, Francesco Costa, et al.
Journal of Cardiovascular Development and Disease|June 25, 2025
Effect of DAPAgliflozin on Myocardial Fibrosis and Ventricular Function in Patients with ST-Segment Elevation Myocardial Infarction-DAPA-STEMI TrialLuis Ortega-Paz, Claudio Laudani, Alessandro Sionis, et al.
Journal of Clinical Medicine|June 12, 2026
Effect of Dapagliflozin on Myocardial Fibrosis After STEMI: A Double-Blind, Placebo-Controlled Randomized TrialLuis Ortega-Paz, Claudio Laudani, Carlos Igor Morr, et al.
Journal of the American Heart Association|February 25, 2025
Sex-Related Differences in the Prognostic Role of Acetylcholine Provocation TestingRiccardo Rinaldi, Michele Russo, Giovanni Occhipinti, et al.
Clinical Pharmacology and Therapeutics|August 28, 2025
Impact of Race on Profiles of Platelet Reactivity and Clinical Outcomes in Clopidogrel-Treated ParticipantsLuis Ortega-Paz, Cameron D Thomas, Claudio Laudani, et al.
International Journal of Cardiology|February 16, 2024
Long-term impact of intravascular ultrasound-guidance for percutaneous coronary intervention on unprotected left main. The IMPACTUS-LM, an observational, multicentric studyFrancesco Bruno, Ovidio de Filippo, Andrea Sardone, et al.
Heart (British Cardiac Society)|April 29, 2026
Derivation and validation of a prediction model for long-term mortality in patients with ST-segment elevation myocardial infarction undergoing percutaneous coronary intervention: the PREDICT-ST-Elevation Myocardial Infarction scoreLuis Ortega-Paz, Claudio Laudani, Salvatore Brugaletta, et al.
Pageof 8